Overview

A Double Blind, Double Dummy, Randomized, Comparative Study Of The Efficacy And Safety Of Valdecoxib 40 Mg Twice Daily, As Needed In The First Menstrual Cycle Day And Then Once A Day, And Piroxicam 40 Mg Once A Day In The Treatment Of Patients With

Status:
Completed

Trial end date:
2003-07-01

Target enrollment:

Participant gender:

Summary

To compare the analgesic efficacy, safety, and tolerability of valdecoxib versus piroxicam in subjects with moderate to severe menstrual cramping pain associated with primary dysmenorrhea.

Phase:

Phase 4

Details

Lead Sponsor:

Pfizer

Treatments:

Piroxicam
Valdecoxib